Presentation is loading. Please wait.

Presentation is loading. Please wait.

Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant 

Similar presentations


Presentation on theme: "Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant "— Presentation transcript:

1 Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant  Ibraheem H. Motabi, Armin Ghobadi, Jingxia Liu, Mark Schroeder, Camille N. Abboud, Amanda F. Cashen, Keith E. Stockler-Goldstein, Geoffrey L. Uy, Ravi Vij, Peter Westervelt, John F. DiPersio  Biology of Blood and Marrow Transplantation  Volume 22, Issue 7, Pages (July 2016) DOI: /j.bbmt Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 OS (A) and PFS (B) after treatment for all patients.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions


Download ppt "Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant "

Similar presentations


Ads by Google